Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders??? Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 14,393 $ 35,491,462 $ (31,519,789) $ 3,986,066
Balance (in Shares) at Dec. 31, 2020 14,393,100      
Equity-based compensation - stock option expense 473,787 473,787
Warrants exercised $ 712 1,424,288 1,425,000
Warrants exercised (in Shares) 712,500      
Equity-based compensation - stock issuances to consultants and employees $ 350 850,550 850,900
Equity-based compensation - stock issuances to consultants and employees (in Shares) 350,000      
Stock options exercised $ 10 14,490 14,500
Stock options exercised (in Shares) 10,000      
Stock issued as consideration for acquisition $ 700 1,059,450 1,060,150
Stock issued as consideration for acquisition (in Shares) 699,980      
Sale of common stock and warrants, net of transaction costs $ 1,105 2,639,898 2,641,003
Sale of common stock and warrants, net of transaction costs (in Shares) 1,104,297      
Net loss (4,833,764) (4,833,764)
Balance at Mar. 31, 2021 $ 17,270 41,953,925 (36,353,553) 5,617,642
Balance (in Shares) at Mar. 31, 2021 17,269,877      
Balance at Dec. 31, 2020 $ 14,393 35,491,462 (31,519,789) 3,986,066
Balance (in Shares) at Dec. 31, 2020 14,393,100      
Net loss       (13,592,482)
Balance at Sep. 30, 2021 $ 20,448 52,291,921 (45,112,271) 7,200,098
Balance (in Shares) at Sep. 30, 2021 20,448,156      
Balance at Mar. 31, 2021 $ 17,270 41,953,925 (36,353,553) 5,617,642
Balance (in Shares) at Mar. 31, 2021 17,269,877      
Equity-based compensation - stock option expense 568,295 568,295
Equity-based compensation - stock issuances to consultants and employees $ 100 274,900 275,000
Equity-based compensation - stock issuances to consultants and employees (in Shares) 100,000      
Sale of common stock and warrants, net of transaction costs $ 1,036 2,807,964 2,809,000
Sale of common stock and warrants, net of transaction costs (in Shares) 1,035,849      
Net loss (4,440,934) (4,440,934)
Balance at Jun. 30, 2021 $ 18,406 45,605,084 (40,794,487) 4,829,003
Balance (in Shares) at Jun. 30, 2021 18,405,726      
Equity-based compensation - stock option expense 640,777 640,777
Equity-based compensation - stock issuances to consultants and employees $ 170 547,930 548,100
Equity-based compensation - stock issuances to consultants and employees (in Shares) 170,000      
Sale of common stock and warrants, net of transaction costs $ 1,872 5,498,130 5,500,002
Sale of common stock and warrants, net of transaction costs (in Shares) 1,872,430      
Net loss (4,317,784) (4,317,784)
Balance at Sep. 30, 2021 $ 20,448 52,291,921 (45,112,271) 7,200,098
Balance (in Shares) at Sep. 30, 2021 20,448,156      
Balance at Dec. 31, 2021 $ 20,947 54,429,979 (50,943,115) 3,507,811
Balance (in Shares) at Dec. 31, 2021 20,946,712      
Equity-based compensation - stock option expense 567,189 567,189
Equity-based compensation - stock issuances to consultants and employees $ 450 415,973 416,423
Equity-based compensation - stock issuances to consultants and employees (in Shares) 450,000      
Sale of common stock and warrants, net of transaction costs $ 2,322 9,121,419 9,123,741
Sale of common stock and warrants, net of transaction costs (in Shares) 2,322,250      
Net loss (2,907,839) (2,907,839)
Balance at Mar. 31, 2022 $ 23,719 64,534,560 (53,850,954) 10,707,325
Balance (in Shares) at Mar. 31, 2022 23,718,962      
Balance at Dec. 31, 2021 $ 20,947 54,429,979 (50,943,115) 3,507,811
Balance (in Shares) at Dec. 31, 2021 20,946,712      
Net loss       (9,864,721)
Balance at Sep. 30, 2022 $ 26,854 66,190,027 (60,807,836) 5,409,045
Balance (in Shares) at Sep. 30, 2022 26,853,962      
Balance at Mar. 31, 2022 $ 23,719 64,534,560 (53,850,954) 10,707,325
Balance (in Shares) at Mar. 31, 2022 23,718,962      
Equity-based compensation - stock option expense 625,816 625,816
Warrants exercised $ 1,865 1,865
Warrants exercised (in Shares) 1,865,000      
Equity-based compensation - stock issuances to consultants and employees $ 270 473,636 473,906
Equity-based compensation - stock issuances to consultants and employees (in Shares) 270,000      
Net loss (3,847,532) (3,847,532)
Balance at Jun. 30, 2022 $ 25,854 65,634,012 (57,698,486) 7,961,380
Balance (in Shares) at Jun. 30, 2022 25,853,962      
Equity-based compensation - stock option expense 477,868 477,868
Equity-based compensation - stock issuances to consultants and employees $ 1,000 78,147 79,147
Equity-based compensation - stock issuances to consultants and employees (in Shares) 1,000,000      
Net loss (3,109,350) (3,109,350)
Balance at Sep. 30, 2022 $ 26,854 $ 66,190,027 $ (60,807,836) $ 5,409,045
Balance (in Shares) at Sep. 30, 2022 26,853,962